Skip to main content
SpringerLink
Log in
SpringerLink
Log in

Trophoblasttumoren

  • Chapter
  • First Online:
Praxisbuch Gynäkologische Onkologie

  • 2657 Accesses

Zusammenfassung

In Mitteleuropa sind Trophoblasttumoren, insbesondere die malignen, sehr selten. Meist werden sie durch extrem hohe HCG-Werte und Metrorrhagien bzw. Abortsymptome entdeckt. Nach Diagnosestellung ist ein rasches, bildgebendes Staging notwendig, um eine Metastasierung auszuschließen oder zu bestätigen. Trophoblasttumoren sind sehr chemosensibel. Deshalb stellt die Chemotherapie die wichtigste Therapieoption dar. In der Nachsorge ist die Überwachung des β-HCG essenziell.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 129.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Literatur

  • AGO, OEGGG und SGGG (2015) S2k Leitlinie Gestational and non-gestational trophoblastic disease

    Google Scholar 

  • Andrijono A, Muhilal M (2010) Prevention of post-mole malignant trophoblastic disease with vitamin A. Asian Pac J Cancer Prev 11:567–570

    PubMed  Google Scholar 

  • Bagshawe K, Dent J, Webb J (1986) Hydatidiform mole in England and Wales 1973–1983. Lancet I: 673–677

    Google Scholar 

  • Bagshawe K, Lawler S, Paradinas F, Dent J, Brown P, Boxer G (1990) Gestational trophoblastic tumours following initial diagnosis of partial hydatidiform mole. Lancet 335:1074

    Article  CAS  Google Scholar 

  • Berkowitz R, Bernstein M, Laborde O, Goldstein D (1994) Subsequent pregnancy experience in patients with gestational trophoblastic disease. J Reprod Med 39:228–232

    CAS  PubMed  Google Scholar 

  • Cole L, Khanlian S, Muller C (2009) Normal production of human chorionic gonadotropin in perimenopausal and menopausal women and after oophorectomy. Int J Gynecol Cancer 19:1556–1559

    Article  Google Scholar 

  • Fang J, Wang S, Han X, An R, Wang W, Xue Y (2012) Role of adjuvant hysterectomy in management of high-risk gestational trophoblastic neoplasia. Int J Gynecol Cancer 22:509–514

    Article  Google Scholar 

  • Goto S, Ino K, Mitsui T et al (2004) Survival rates of patients with choriocarcinoma treated with chemotherapy without hysterectomy: effects of anticancer agents on subsequent births. Gynecol Oncol 93:529–535

    Article  CAS  Google Scholar 

  • Hoekstra A, Keh P, Lurain J (2004) Placental site trophoblastic tumor: a review of 7 cases and their implications for prognosis and treatment. J Reprod Med 49:447–452

    PubMed  Google Scholar 

  • Huang M, Pinto A, Castillo R, Slomovitz M (2017) Complete serologic response to pembrolizumab in a woman with chemoresistant metastatic choriocarcinoma. J Clin Oncol 3173

    Google Scholar 

  • Knox S, Brooks S, Wong-You-Cheong J et al (2002) Choriocarcinoma and epithelial trophoblastic tumor: successful treatment of relapse with hysterectomy and high-dose chemotherapy with peripheral stem cell support. Gynecol Oncol 85:204–208

    Article  Google Scholar 

  • Köchli OR (1994) Staging der malignen Trophoblasterkrankungen: Ein Dilemma. Gynakol Geburtshilfe Rundsch 34:3–6

    Article  Google Scholar 

  • Köchli OR, Schär G, Sevin BU et al (1995) In vitro chemosensitivity of paclitaxel and other chemotherapeutic agents in malignant gestational trophoblastic neoplasms. Anti Cancer Drugs 6:94–100

    Article  Google Scholar 

  • Kohorn EI (2001) The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assesssment. Int J Gynecol Cancer 11:73–77

    Article  CAS  Google Scholar 

  • Lan C, Li Y, He J, Liu J (2010) Placental site trophoblastic tumor: lymphatic spread and possible target markers. Gynecol Oncol 116:430–570

    Article  Google Scholar 

  • Li-Pai C, Shu-Mo C, Jian-Xuan F, Zi-Ting L (1995) PEBA regimen (cisplatin, etoposide, bleomycin, and adriamycin) in the treatment of drug-resistant choriocarcinoma. Gynecol Oncol 56:231–234

    Article  Google Scholar 

  • Newlands E, Bagshawe K, Begent R, Rustin G, Holden L (1991) Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumors, 1979–1989. Br J Obstet Gynaecol 98:550–557

    Article  CAS  Google Scholar 

  • Newlands E, Mulholland P, Holden L et al (2000) Etoposide and cisplatin/etoposide, methotrexate, and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental trophoblastic tumors. J Clin Oncol 18:854–859

    Article  CAS  Google Scholar 

  • Ngan H (2004) The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia. Int J Gynecol Cancer 14:202–205

    Article  CAS  Google Scholar 

  • Seckl M, Fisher R, Salerno G et al (2000) Choriocarcinoma and partial hydatidiform moles. Lancet 356:36–39

    Article  CAS  Google Scholar 

  • Soper J, Evans A, Rodriguez G et al (1995) Etoposide-platin combination therapy for chemorefractory gestational trophoblastic disease. Gynecol Oncol 56:421–424

    Article  CAS  Google Scholar 

  • Woolas R, Bower M, Newlands E et al (1998) Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome. Br J Obstet Gynecol 105:1032–1035

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Privatklinik Zürich-Bethanien, Gynäkologisch-onkologische Praxis Brustzentrum, Zürich, Schweiz

    Ossi R. Köchli

  2. Universitätsklinik für Frauenheilkunde und Geburtshilfe, Medizinische Universität Graz, Graz, Österreich

    Edgar Petru

  3. Mayo Clinic Florida, Ponte Vedra Beach, Florida, USA

    Bernd-Uwe Sevin

Authors
  1. Ossi R. Köchli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Edgar Petru
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Bernd-Uwe Sevin
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Universitätsklinik für Frauenheilkunde und Geburtshilfe, Medizinische Universität Graz, Graz, Austria

    Edgar Petru

  2. Klinik für Gynäkologie, UniversitätsSpital Zürich, Zürich, Switzerland

    Daniel Fink

  3. Gynäkologisch-onkologische Praxis, BrustCentrum, Privatklinik Zürich-Bethanien, Zürich, Switzerland

    Ossi R. Köchli

  4. German Breast Group Forschungs GmbH, Neu-Isenburg, Germany

    Sibylle Loibl

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer-Verlag GmbH Deutschland, ein Teil von Springer Nature

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Köchli, O.R., Petru, E., Sevin, BU. (2019). Trophoblasttumoren. In: Petru, E., Fink, D., Köchli, O., Loibl, S. (eds) Praxisbuch Gynäkologische Onkologie. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-57430-0_14

Download citation

  • DOI: https://doi.org/10.1007/978-3-662-57430-0_14

  • Published:

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-662-57429-4

  • Online ISBN: 978-3-662-57430-0

  • eBook Packages: Medicine (German Language)

Publish with us

Policies and ethics

Search

Navigation